SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF is drawing attention as investors weigh the impact of regional conflicts and geopolitical instability on global tanker logistics and shipping rates. The community is debating whether the current price action reflects a structural shift in maritime capacity or temporary volatility driven by the escalating situation near critical chokepoints.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML Holding NV is currently trending as investors weigh strong AI-driven demand and a record backlog against potential headwinds from new U.S. export controls and broader semiconductor market volatility. Community sentiment remains mixed, with bullish long-term investors pointing to the company's EUV lithography monopoly, while others express caution regarding valuation premiums and geopolitical risks impacting the global supply chain.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending as investors monitor bank earnings and the rollout of new credit default swaps tied to private credit, while the firm also navigates internal scrutiny regarding historical ties to Jeffrey Epstein. The community is actively debating the firm's leadership, potential staff reductions, and its role in managing major upcoming deals like the SpaceX IPO.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as the community leans into its legacy as a long-standing parody project, with supporters highlighting its early origins and the goal of achieving billion-dollar status. Discussion centers on the project's shift from a joke to an on-chain asset, with the community actively comparing its potential to the broader cryptocurrency market while leveraging the humor inherent in its branding.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing intense volatility as the market digests the fallout from stalled negotiations in the Strait of Hormuz, with community sentiment deeply divided between fears of further geopolitical escalation and optimism for a broader crypto recovery. While some traders are bracing for a potential downturn due to rising energy costs and macro uncertainty, others are actively tracking ETF inflows and technical indicators for signs of a sustained breakout.

Maulcoin

Maulcoin is capturing market attention as its community pushes to achieve significant milestones, including plans for upcoming airdrops for verified holders. Investors are actively discussing the coin's organic growth and the potential for long-term value appreciation, fueling a strong sense of momentum among those committed to holding the asset.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE is gaining significant traction as the community rallies around the restoration of iconic internet meme tools, positioning the asset as a culture-driven project rather than a typical speculative coin. Supporters are actively engaging in 'bag working' and meme creation, fueled by a collective belief in the historical significance of the original Rage Guy character.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining community momentum as supporters highlight the project's strategic token supply locks and upcoming one-year anniversary. Investors are expressing high conviction, focusing on the brand's pivot toward viral positivity-themed content and a long-term commitment to ecosystem growth.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll is currently trending as the community leans into its legacy as a cultural meme, with active discussions focusing on its historical origins in rage comics and its expanding presence across the Solana ecosystem. Investors are comparing it to other established meme coins, emphasizing the strength of its community "diamond hands" and its potential for long-term growth as part of a broader "culture coin" narrative.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is generating intense community debate as investors weigh its potential for a supply-driven rally against frustration over its prolonged underperformance relative to other DeFi protocols. While some traders point to the coin's capped supply and ongoing governance developments as catalysts for a rebound, many voices express skepticism, highlighting persistent downward pressure and the competitive dominance of alternatives like AAVE.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SG Americas Securities LLC Cuts Stock Holdings in Structure Therapeutics Inc. Sponsored ADR $GPCR

SG Americas Securities LLC lowered its holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 74.4% during the 4th quarter, according to the company in its most recent...

Aberdeen Group plc Sells 322,000 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR

Aberdeen Group plc cut its holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 54.9% during the fourth quarter, according to its most recent Form 13F filing with the...

How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval

LLY wins FDA nod for oral obesity pill Foundayo, boosting shares as it eyes billions in sales and a fast catch-up to rivals in the booming GLP-1 market.

Capricorn Fund Managers Ltd Invests $17.57 Million in Structure Therapeutics Inc. Sponsored ADR $GPCR

Capricorn Fund Managers Ltd bought a new stake in shares of Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) during the fourth quarter, according to the company in its most...

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eighteen research firms that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with...

Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 10.8% - What's Next?

Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 10.8% - Still a Buy...

LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill?

Eli Lilly stock gains on FDA nod for oral obesity drug Foundayo, expanding its portfolio and patient access, setting up a fresh showdown with Novo Nordisk in the GLP-1 market.

Exchange Traded Concepts LLC Sells 32,241 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR

Exchange Traded Concepts LLC lowered its holdings in Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR - Free Report) by 55.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 25,981 shares of the company's stock after...

What's Going On With Structure Therapeutics Stock On Wednesday?

Structure Therapeutics shares rose, likely driven by FDA approval of a competing obesity treatment, boosting sentiment.read more...

<ul class="summary-bullets"><li>Earlier this month, Viking announced competition for patient enrollment in its late-stage clinical trial of subcutaneous VK2735, the company's experimental drug for weight loss.</li><li>Structure Therapeutics expects to initiate late-stage clinical development of its experimental drug Aleniglipron in the second half of 2026.</li><li>According to data from Koyfin, GPCR stock carries a 12-month average target of $109, while VKTX stock carries a 12-month average target of $92.72.</li></ul>Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are capturing intense investor attention as obesity treatments are increasingly deemed the largest growth engine in the U.S. pharmaceutical industry.Eli Lilly (LLY) and Novo Nordisk (NVO) currently dominate the current obesity drug market. Smaller firms Viking and Structure are both developing drugs for obesity even as bigger names like Pfizer (PFE) and AstraZeneca (AZN) also seek to enter the competition ring.<h2 class="st-heading-2">Viking, Structure’s Obesity Pipelines</h2>Earlier this month, Viking announced competition for patient enrollment in its late-stage clinical trial of subcutaneous VK2735, the company's experimental drug for weight loss. The trial enrolled about 1,000 patients with type 2 diabetes and who have obesity or who are overweight, the company said.The primary endpoint of the study is the percent change in body weight from baseline after 78 weeks of treatment for participants receiving VK2735 as compared to placebo. In a mid-stage trial, patients achieved up to 14.7% mean weight loss in 13 weeks on the drug.The dual agonist VK2735 is being developed in both oral and subcutaneous formulations. Viking is now looking forward to advancing the oral version of its experimental obesity drug into late-stage study in the third-quarter (Q3) of 2026.Meanwhile, Structure said earlier this month that its experimental drug Aleniglipron achieved clinically meaningful and statistically significant placebo-adjusted mean weight loss of 16.3% at the 180 mg dose and 16.0% at the 240 mg dose at 44 weeks in a mid-stage trial. The company now expects to initiate late-stage clinical development of the drug in the second half of 2026.The company also has other investigational obesity drugs called ACCG-2671 and ANPA-0073 currently in early stage studies. &nbsp;<h2 class="st-heading-2">Who Offers Better Upside?</h2>According to data from Koyfin, GPCR carries a 12-month average target of $109, implying a 147.95% upside potential from its last close. The stock holds a consensus analyst rating of 'Strong Buy', with 15 analysts rating the stock ‘Buy’ or higher while one rates it a ‘Hold’.Meanwhile, VKTX carries a 12-month average target of $92.72, representing a 209.80% upside from current levels. The stock also holds a consensus 'Strong Buy' rating, with 17 analysts rating it ‘Buy’ or higher while two hate it ‘Hold’.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment toward VKTX stock stayed within the ‘neutral’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.Meanwhile, sentiment toward GPCR stock stayed within the ‘bearish’ territory, while message volume fell from ‘normal’ to ‘low’ levels. &nbsp;<a href="https://stocktwits.com/symbol/VKTX">VKTX stock</a> has climbed 24% this year, while <a href="https://stocktwits.com/symbol/GPCR">GPCR</a> surged 154%.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/gm-doubles-down-on-heavy-duty-gas-trucks-amid-massive-ev-writedowns-report/cZERzvHRINm">GM Doubles Down On Heavy-Duty Gas Trucks Amid Massive EV Writedowns: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Injections for weight loss with Semaglutide. An obese woman gives a hormone glucagon-like peptide-1 (GLP-1) injection into the abdomen with a pen syringe.

VKTX Vs. GPCR: Which Obesity Drug Developer Does Wall Street See With The Bigger Upside?

According to analyst valuations, Structure Therapeutics may offer 148% potential upside, compared to an upside of 210% on Viking Therapeutics. 

Equity

According to analyst valuations, Structure Therapeutics may offer 148% potential upside, compared to an upside of 210% on Viking Therapeutics. 


Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

GPCR
Structure Therapeutics Inc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GPCR News

GPCRStructure Therapeutics Inc - ADR